Current status: 1130 hESC lines, 7974 hiPSC lines, and 205 clinical studies, and 2406 certificates
Monthly statistic from Jul 1, 2026
Posted on July 1, 2026
| total lines | 9104 |
| hESC lines | 1130 |
| hiPSC lines | 7974 |
| derivation countries | 52 |
| projects | 346 |
| providers | 1062 |
| clinical studies | 205 |
| subclones | 4130 |
| certificates | 2406 |
| cell line certificates | 2246 |
| project certificates | 160 |